To investigate the clinical significance of SMAD5 expression in GC patients, immunohistochemical (IHC) staining was used to detect SMAD5 expression in a human tissue array of the abovementioned 41 clinical gastric cancer tissues and adjacent nontumour tissue samples. Here, SMAD5 is linked to gastric cancer.